Variation Biotechnologies, Inc. (VBI), an emerging leader in the discovery and development of novel vaccines to fight infectious diseases, reported that the company's proprietary influenzavaccine triggered a robust immune response and provided protection against the H1N1 strain of influenza. The data were obtained from preclinical testing of ferrets inoculated with Variation's proprietary influenza vaccine and challenged with live H1N1. Data from this study were recently presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting in San Francisco, California.
The study's primary objective was to demonstrate the...
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry